• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtech investment in Minnesota falls back to earth

Medtech investment in Minnesota falls back to earth

April 17, 2015 By Scott Wooldridge

Medtech investment in Minnesota falls back to earth

After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.

Officials with the Minneapolis-based trade association said yesterday that the 1st quarter of 2015 saw $41 million in total investments in the North Star state. Most of that investment went to the medical device field, always a strong industry in the state. In Q1, 57% of the companies raising money were from the medical device field, and 87% of the total funding came in that area.

The numbers were down more than 45% from Q1 2014, which saw $75 million in investment, according to the report. But according to Cheryl Matter, PhD, director of research and intelligence at LifeScience Alley, the numbers are similar or better than Q1s from other recent years.

"2014 was an exceptional year. Almost every quarter was above we’ve seen for the last 6 years. It was the all-time high. So this is more in line with what we’ve seen [recently]," Matter said

Medtech is "probably our strongest sector here," she added.

"It’s always a pretty large chunk of the investment," Matter said. "Part of that success is because of the talent here, and the workforce. The industry here is strong and we’ve been able to weather a lot of the industry ups and downs."

The 2 largest 1st-quarter investment deals noted by the report were the $10 million raised by Sunshine Heart of Eden Prairie, which is developing a therapy for heart failure patients, and an $11 million round for Osprey Medical (ASX:OSP), a Minnetonka-based firm that’s developed technology designed to protect kidney function in patients being treated for heart problems.

A total of 23 companies reported investment deals in the 1st quarter, down from 44 a year ago. Thirteen of the companies were medical device firms, 5 were health information technology firms; diagnostics, pharmaceutical and research firms made up the remaining deals.

Overall, Matter said, the Minnesota industry was off to a good start for 2015.

"We had a really great 2014, it was a peak year," Matter said. "This Q1 is solid, it’s line with what we’ve seen in previous years, and it’s something we can build on."

Filed Under: Funding Roundup, News Well Tagged With: Medical Alley, Minnesota, Osprey Medical, Sunshine Heart Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy